Abstract
Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide RNAi screening, we have identified proteins required for the processing of the EWS-FLI1 pre-mRNA. We show that Ewing sarcoma cells harboring a genomic breakpoint that retains exon 8 of EWSR1 require the RNA-binding protein HNRNPH1 to express in-frame EWS-FLI1. We also demonstrate the sensitivity of EWS-FLI1 fusion transcripts to the loss of function of the U2 snRNP component, SF3B1. Disrupted splicing of the EWS-FLI1 transcript alters EWS-FLI1 protein expression and EWS-FLI1-driven expression. Our results show that the processing of the EWS-FLI1 fusion RNA is a potentially targetable vulnerability in Ewing sarcoma cells.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, N.I.H., Intramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Base Sequence
-
Binding Sites
-
Calmodulin-Binding Proteins / antagonists & inhibitors
-
Calmodulin-Binding Proteins / genetics
-
Calmodulin-Binding Proteins / metabolism
-
Cell Line, Tumor
-
Cell Survival
-
Exons
-
Gene Expression Regulation, Neoplastic
-
Heterogeneous-Nuclear Ribonucleoprotein Group F-H / antagonists & inhibitors
-
Heterogeneous-Nuclear Ribonucleoprotein Group F-H / genetics
-
Heterogeneous-Nuclear Ribonucleoprotein Group F-H / metabolism
-
Humans
-
Microfilament Proteins / antagonists & inhibitors
-
Microfilament Proteins / genetics
-
Microfilament Proteins / metabolism
-
Oncogene Proteins, Fusion / antagonists & inhibitors
-
Oncogene Proteins, Fusion / genetics
-
Oncogene Proteins, Fusion / metabolism*
-
Phosphoproteins / antagonists & inhibitors
-
Phosphoproteins / genetics
-
Phosphoproteins / metabolism
-
Proto-Oncogene Protein c-fli-1 / antagonists & inhibitors
-
Proto-Oncogene Protein c-fli-1 / genetics
-
Proto-Oncogene Protein c-fli-1 / metabolism*
-
RNA Interference
-
RNA Precursors / metabolism
-
RNA Splicing
-
RNA Splicing Factors
-
RNA, Small Interfering / metabolism
-
RNA-Binding Protein EWS / antagonists & inhibitors
-
RNA-Binding Protein EWS / genetics
-
RNA-Binding Protein EWS / metabolism*
-
RNA-Binding Proteins / antagonists & inhibitors
-
RNA-Binding Proteins / genetics
-
RNA-Binding Proteins / metabolism
-
Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors
-
Receptors, Cytoplasmic and Nuclear / genetics
-
Receptors, Cytoplasmic and Nuclear / metabolism
-
Ribonucleoprotein, U2 Small Nuclear / antagonists & inhibitors
-
Ribonucleoprotein, U2 Small Nuclear / genetics
-
Ribonucleoprotein, U2 Small Nuclear / metabolism
-
Sarcoma, Ewing / pathology
-
Trans-Activators
-
Transcription Factors / antagonists & inhibitors
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
Substances
-
Calmodulin-Binding Proteins
-
EWS-FLI fusion protein
-
EWSR1 protein, human
-
FLII protein, human
-
Heterogeneous-Nuclear Ribonucleoprotein Group F-H
-
Microfilament Proteins
-
Oncogene Proteins, Fusion
-
Phosphoproteins
-
Proto-Oncogene Protein c-fli-1
-
RNA Precursors
-
RNA Splicing Factors
-
RNA, Small Interfering
-
RNA-Binding Protein EWS
-
RNA-Binding Proteins
-
Receptors, Cytoplasmic and Nuclear
-
Ribonucleoprotein, U2 Small Nuclear
-
SF3B1 protein, human
-
SUPT6H protein, human
-
Trans-Activators
-
Transcription Factors